Publication
Mesenchymal stromal cells for bone trauma, defects, and disease: Considerations for manufacturing, clinical translation, and effective treatments
Downloadable Content
- Persistent URL
- Last modified
- 06/25/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2023-06-01
- Publisher
- Elsevier Inc
- Publication Version
- Copyright Statement
- . © 2024 Elsevier B.V
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- Volume
- 18
- Start Page
- 101656
- End Page
- 101656
- Abstract
- Bone is a complex tissue capable of natural repair to injury, however, the healing process is often impaired by the untoward effects of trauma, defects, and disease. Thus, therapeutic modalities, including the use of cells involved in the body's natural healing processes, are investigated to promote or complement natural bone repair. Herein, several modalities and innovative approaches for using mesenchymal stromal cells (MSCs) to treat bone trauma, defects, and diseases are discussed. Given the evidence that supports the promising potential of MSCs, we highlight important considerations for advancing the clinical use of MSCs including the standardization of procedures from the harvest to delivery to patients and realized solutions to manufacturing. A better understanding of the current approaches implemented to address the challenges of using therapeutic MSCs will help improve study designs and, ultimately, achieve effective outcomes for restoring bone health.
- Author Notes
- Keywords
- Research Categories
- Biology, Cell
- Engineering, Biomedical
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - w7r5b.pdf | Primary Content | 2025-06-04 | Public | Download |